Page last updated: 2024-08-17

medroxyprogesterone acetate and Stroke

medroxyprogesterone acetate has been researched along with Stroke in 26 studies

Research

Studies (26)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	19 (73.08)	29.6817
2010's	6 (23.08)	24.3611
2020's	1 (3.85)	2.80

Authors

Authors	Studies
Anderson, GL; Aragaki, AK; Chlebowski, RT; Gass, M; Johnson, KC; Kuller, LH; Manson, JE; Prentice, RL; Rossouw, JE; Shadyab, AH; Stefanick, ML; Wactawski-Wende, J; Wallace, R	1
Li, J; Liu, X; Yang, D; Yuan, Z	1
Anderson, G; Aragaki, AK; Beresford, SA; Cauley, JA; Chlebowski, RT; Eaton, CB; Gass, M; Howard, BV; Hsia, J; Jackson, RD; Johnson, KC; Kooperberg, C; Kuller, LH; LaCroix, AZ; Lewis, CE; Limacher, M; Liu, S; Manson, JE; Margolis, KL; Martin, LW; O'Sullivan, MJ; Ockene, JK; Powell, LH; Prentice, RL; Rossouw, JE; Simon, MS; Stefanick, ML; Thomson, CA; Van Horn, L; Vitolins, MZ; Wactawski-Wende, J; Wallace, RB; Wassertheil-Smoller, S	1
Gurney, EP; Nachtigall, LE; Nachtigall, MJ; Naftolin, F	1
Prentice, RL	1
Aedo, S; Barriga, P; Blümel, JE; Brantes, S; Campodónico, Í; Cavada, G; Chedraui, P; Fica, J; Irribarra, C; Vallejo, M	1
Allison, M; Anderson, GL; Brzyski, R; Jackson, RD; Johnson, KC; Kuller, LH; Lane, DS; Langer, RD; Manson, JE; Ockene, J; Pettinger, M; Prentice, RL; Rossouw, JE; Sarto, G; Wactawski-Wende, J	1
Weisberg, E	1
Anderson, GL; Beresford, SA; Howard, BV; Jackson, RD; Johnson, KC; Kooperberg, C; Kotchen, JM; LaCroix, AZ; Ockene, J; Prentice, RL; Rossouw, JE; Stefanick, ML	1
Reid, RL	1
Aragaki, A; Baird, A; Black, H; Curb, JD; Heiss, G; Hendrix, SL; Kooperberg, C; Kotchen, T; Laowattana, S; Limacher, M; Mysiw, WJ; Rossouw, JE; Safford, M; Stein, E; Wassertheil-Smoller, S	1
Wickelgren, I	1
Heinemann, V; Parhofer, K	1
Shapiro, S	3
Bushnell, CD; Goldstein, LB; Lin, F; Newby, LK; Simon, JA; Yaffe, K	1
Martin, KA; McDonnell, DP; Turgeon, JL; Wise, PM	1
Aschenbrenner, DS	1
Birkhaeuser, MH	1
Heikkinen, J; Timonen, U; Vaheri, R	1
Singh, M	1
Lobo, RA	1
Colditz, GA; Grodstein, F; Manson, JE; Speizer, FE; Stampfer, MJ; Willett, WC	1

Reviews

8 review(s) available for medroxyprogesterone acetate and Stroke

Article	Year
Effect of hormone replacement therapy on cardiovascular outcomes: a meta-analysis of randomized controlled trials. PloS one, 2013, Volume: 8, Issue:5 Topics: Cardiovascular Diseases; Estrogens; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome	2013
The Women's Health Initiative trial and related studies: 10 years later: a clinician's view. The Journal of steroid biochemistry and molecular biology, 2014, Volume: 142 Topics: Aged; Atherosclerosis; Breast Neoplasms; Calcium; Cognition; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fractures, Bone; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progestins; Randomized Controlled Trials as Topic; Risk Assessment; Stroke; Testosterone; Venous Thromboembolism; Vitamin D; Women's Health	2014
Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke. Seminars in reproductive medicine, 2014, Volume: 32, Issue:6 Topics: Aged; Aged, 80 and over; Brain Ischemia; Breast Neoplasms; Coronary Disease; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Evidence-Based Medicine; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Progestins; Risk Factors; Stroke; United States	2014
Hormone therapy: physiological complexity belies therapeutic simplicity. Science (New York, N.Y.), 2004, May-28, Volume: 304, Issue:5675 Topics: Aged; Animals; Cardiovascular Physiological Phenomena; Estrogen Replacement Therapy; Estrogens; Female; Humans; Lipid Metabolism; Medroxyprogesterone Acetate; Middle Aged; Neuroprotective Agents; Progesterone; Randomized Controlled Trials as Topic; Receptors, Estrogen; Receptors, Progesterone; Signal Transduction; Stroke	2004
HRT Reconsidered: What should you tell patients about it now? The American journal of nursing, 2004, Volume: 104, Issue:6 Topics: Aged; Cardiovascular Diseases; Clinical Trials as Topic; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Nurses; Patient Education as Topic; Postmenopause; Risk Factors; Stroke	2004
Progestins and neuroprotection: are all progestins created equal? Minerva endocrinologica, 2007, Volume: 32, Issue:2 Topics: Aging; Alzheimer Disease; Animals; Brain; Brain Injuries; Contraceptive Agents, Female; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Neuroprotective Agents; Progesterone; Progestins; Receptors, Progesterone; Signal Transduction; Spinal Injuries; Stroke; Women's Health	2007
Recent epidemiological evidence relevant to the clinical management of the menopause. Climacteric : the journal of the International Menopause Society, 2007, Volume: 10 Suppl 2 Topics: Breast Neoplasms; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Evidence-Based Medicine; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Menopause; Ovarian Neoplasms; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stroke; United States; Venous Thromboembolism; Women's Health	2007
Menopause and stroke and the effects of hormonal therapy. Climacteric : the journal of the International Menopause Society, 2007, Volume: 10 Suppl 2 Topics: Aged; Estrogen Replacement Therapy; Estrogens; Evidence-Based Medicine; Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Randomized Controlled Trials as Topic; Risk Factors; Sex Factors; Stroke; United States; Venous Thrombosis; Women's Health	2007

Trials

7 trial(s) available for medroxyprogesterone acetate and Stroke

Article	Year
Randomized Trial Evaluation of the Benefits and Risks of Menopausal Hormone Therapy Among Women 50-59 Years of Age. American journal of epidemiology, 2021, 02-01, Volume: 190, Issue:3 Topics: Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hip Fractures; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasms; Postmenopause; Proportional Hazards Models; Pulmonary Embolism; Stroke	2021
Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA, 2013, Oct-02, Volume: 310, Issue:13 Topics: Aged; Breast Neoplasms; Colorectal Neoplasms; Coronary Disease; Drug Therapy, Combination; Endometrial Neoplasms; Estrogens; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hip Fractures; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Pulmonary Embolism; Quality of Life; Risk; Stroke; Treatment Outcome; United States	2013
Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. American journal of epidemiology, 2009, Jul-01, Volume: 170, Issue:1 Topics: Aged; Breast Neoplasms; Colorectal Neoplasms; Contraceptive Agents, Female; Coronary Disease; Endometrial Neoplasms; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Fractures, Bone; Humans; Incidence; Medroxyprogesterone Acetate; Menopause; Middle Aged; Postmenopause; Progestins; Pulmonary Embolism; Retrospective Studies; Risk Factors; Stroke; Survival Rate; Thrombosis; Time Factors; Washington	2009
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA, 2002, Jul-17, Volume: 288, Issue:3 Topics: Aged; Breast Neoplasms; Clinical Trials Data Monitoring Committees; Colorectal Neoplasms; Coronary Disease; Endometrial Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fractures, Bone; Humans; Medroxyprogesterone Acetate; Middle Aged; Myocardial Infarction; Postmenopause; Progesterone Congeners; Proportional Hazards Models; Pulmonary Embolism; Risk; Stroke; Survival Analysis; Thrombosis; Treatment Outcome	2002
Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA, 2003, May-28, Volume: 289, Issue:20 Topics: Aged; Biomarkers; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Progesterone Congeners; Proportional Hazards Models; Risk Factors; Stroke; Survival Analysis	2003
[Risk and benefits of hormone replacement therapy by postmenopausal women. WHI-Study]. Der Internist, 2003, Volume: 44, Issue:7 Topics: Aged; Breast Neoplasms; Colorectal Neoplasms; Coronary Disease; Endometrial Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fractures, Bone; Hormone Replacement Therapy; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Myocardial Infarction; Postmenopause; Progesterone Congeners; Proportional Hazards Models; Pulmonary Embolism; Risk Assessment; Stroke; Survival Analysis; Thrombosis; Treatment Outcome; United States; Women's Health	2003
A 10-year follow-up of postmenopausal women on long-term continuous combined hormone replacement therapy: Update of safety and quality-of-life findings. The journal of the British Menopause Society, 2006, Volume: 12, Issue:3 Topics: Breast Neoplasms; Dose-Response Relationship, Drug; Endometrial Neoplasms; Estradiol; Estrogens, Conjugated (USP); Female; Finland; Follow-Up Studies; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Postmenopause; Quality of Life; Stroke; Treatment Outcome	2006

Other Studies

11 other study(ies) available for medroxyprogesterone acetate and Stroke

Article	Year
Women's Health Initiative estrogen plus progestin clinical trial: a study that does not allow establishing relevant clinical risks. Menopause (New York, N.Y.), 2015, Volume: 22, Issue:12 Topics: Breast Neoplasms; Colorectal Neoplasms; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hip Fractures; Humans; Medroxyprogesterone Acetate; Monte Carlo Method; Placebos; Proportional Hazards Models; Pulmonary Embolism; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Survival Rate; Women's Health	2015
Contraceptive options for women in selected circumstances. Best practice & research. Clinical obstetrics & gynaecology, 2010, Volume: 24, Issue:5 Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult	2010
Translating the latest scientific advances into clinical practice. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2002, Volume: 24, Issue:10 Topics: Breast Neoplasms; Coronary Disease; Diffusion of Innovation; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Evidence-Based Medicine; Female; Gynecology; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Patient Selection; Practice Patterns, Physicians'; Risk Factors; Stroke; Time Factors	2002
Health risks outweigh benefits for combined estrogen plus progestin. Clinical trial stopped early in major study. Ginecologia y obstetricia de Mexico, 2002, Volume: 70 Topics: Aged; Breast Neoplasms; Colorectal Neoplasms; Coronary Disease; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Hip Fractures; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Placebos; Postmenopause; Progesterone Congeners; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Time Factors; Venous Thrombosis	2002
Estrogen research. Brain researchers try to salvage estrogen treatments. Science (New York, N.Y.), 2003, Nov-14, Volume: 302, Issue:5648 Topics: Age Factors; Aged; Animals; Brain; Cognition; Dementia; Drug Combinations; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neurons; Neuroprotective Agents; Patient Selection; Progesterone; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Time Factors	2003
Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial. Climacteric : the journal of the International Menopause Society, 2003, Volume: 6, Issue:4 Topics: Bias; Breast Neoplasms; Contraceptive Agents, Female; Coronary Disease; Data Interpretation, Statistical; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Incidence; Medroxyprogesterone Acetate; Pulmonary Embolism; Randomized Controlled Trials as Topic; Research Design; Risk; Stroke	2003
Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS). Neurology, 2004, Mar-23, Volume: 62, Issue:6 Topics: Aged; Cohort Studies; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Ischemic Attack, Transient; Medroxyprogesterone Acetate; Postmenopause; Randomized Controlled Trials as Topic; Risk; Stroke; Survival Analysis	2004
Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat. Prescrire international, 2004, Volume: 13, Issue:71 Topics: Breast Neoplasms; Coronary Disease; Dementia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Europe; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Randomized Controlled Trials as Topic; Risk Assessment; Stroke; Thromboembolism; Time Factors; United States; Women's Health	2004
The Women's Health Initiative conundrum. Archives of women's mental health, 2005, Volume: 8, Issue:1 Topics: Adult; Age Factors; Aged; Bias; Breast Neoplasms; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Patient Selection; Progesterone Congeners; Research Design; Stroke; United States; Women's Health	2005
Risk of cardiovascular disease in relation to the use of combined postmenopausal hormone therapy: detection bias and resolution of discrepant findings in two Women's Health Initiative studies. Climacteric : the journal of the International Menopause Society, 2006, Volume: 9, Issue:6 Topics: Aged; Cardiovascular Diseases; Confounding Factors, Epidemiologic; Coronary Disease; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Myocardial Infarction; Postmenopause; Randomized Controlled Trials as Topic; Risk Assessment; Stroke; Thromboembolism; Time Factors; Women's Health	2006
A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Annals of internal medicine, 2000, Dec-19, Volume: 133, Issue:12 Topics: Adult; Aged; Cardiovascular Diseases; Coronary Disease; Drug Administration Schedule; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Myocardial Infarction; Postmenopause; Prospective Studies; Regression Analysis; Risk Factors; Stroke	2000